|
| 37656609 | CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND. | Am J Epidemiol | 2024 |
| 32361726 | Treatment outcome in adults with chronic fatigue syndrome: a prospective study in England based on the CFS/ME National Outcomes Database. | QJM | 2023 |
| 37757876 | Comparative Effectiveness of Dynamic Treatment Strategies for Medication Use and Dosage: Emulating a Target Trial Using Observational Data. | Epidemiology | 2023 |
| 37755828 | Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review. | JAMA Netw Open | 2023 |
| 37832567 | HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis. | Lancet HIV | 2023 |
| 37777287 | All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration. | Lancet Public Health | 2023 |
| 37923486 | Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration. | Lancet HIV | 2023 |
| 36958365 | Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. | Lancet HIV | 2023 |
| 37338017 | Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies. | J Viral Hepat | 2023 |
| 37435838 | Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies. | Health Technol Assess | 2023 |
| 37199601 | Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation. | AIDS | 2023 |
| 37165393 | Correction: The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. | BMC Health Serv Res | 2023 |
| 37363796 | Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study. | Lancet Reg Health Eur | 2023 |
| 37066200 | sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies. | medRxiv | 2023 |
| 37126810 | Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data. | Ann Intern Med | 2023 |
| 36883578 | Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study. | Clin Infect Dis | 2023 |
| 36921925 | Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP. | BMJ | 2023 |
| 36720568 | Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study. | BMJ Open | 2023 |
| 36680646 | Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies. | Eur J Epidemiol | 2023 |
| 36658423 | The impact of the COVID-19 pandemic on cardiovascular disease prevention and management. | Nat Med | 2023 |
| 36265880 | Early-life and health behaviour influences on lung function in early adulthood. | Eur Respir J | 2023 |
| 35192597 | Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England. | PLoS Med | 2022 |
| 35659335 | Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. | Lancet HIV | 2022 |
| 35487318 | Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction (NIHR Health Informatics Collaborative: TROP-CABG study). | Int J Cardiol | 2022 |
| 35858698 | Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records. | BMJ | 2022 |
| 36121907 | Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. | Circulation | 2022 |
| 35876478 | Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies<sup>1</sup>. | Emerg Infect Dis | 2022 |
| 35192610 | Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study. | PLoS Med | 2022 |
| 33166064 | Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: A review. | Res Synth Methods | 2021 |
| 33836825 | Primary Care implementation of Germ Defence, a digital behaviour change intervention to improve household infection control during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial. | Trials | 2021 |
| 34641870 | An informatics consult approach for generating clinical evidence for treatment decisions. | BMC Med Inform Decis Mak | 2021 |
| 34534516 | Considerations in boosting COVID-19 vaccine immune responses. | Lancet | 2021 |
| 34237063 | Time to reconsider the role of ribavirin in Lassa fever. | PLoS Negl Trop Dis | 2021 |
| 34228774 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. | JAMA | 2021 |
| 33429295 | The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. | Drug Alcohol Depend | 2021 |
| 31433491 | Improving early warning scores - more data, better validation, the same response. | Anaesthesia | 2020 |
| 31964641 | Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study. | BMJ | 2020 |
| 31857745 | Adjusting trial results for biases in meta-analysis: combining data-based evidence on bias with detailed trial assessment. | J R Stat Soc Ser A Stat Soc | 2020 |
| 31851427 | Ten questions to consider when interpreting results of a meta-epidemiological study-the MetaBLIND study as a case. | Res Synth Methods | 2020 |
| 32003460 | Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies. | Int J Cancer | 2020 |
| 32092231 | The median and the mode as robust meta-analysis estimators in the presence of small-study effects and outliers. | Res Synth Methods | 2020 |
| 33184277 | Collider bias undermines our understanding of COVID-19 disease risk and severity. | Nat Commun | 2020 |
| 33067802 | Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically Matched Participants With and Without HIV. | Alcohol Clin Exp Res | 2020 |
| 32861307 | Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data. | Lancet | 2020 |
| 32831155 | Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. | Trials | 2020 |
| 32876694 | Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. | JAMA | 2020 |
| 33020224 | Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK. | Heart | 2020 |
| 32810233 | Can machine learning improve mortality prediction following cardiac surgery? | Eur J Cardiothorac Surg | 2020 |
| 32128803 | Improving early warning scores - more data, better validation, the same response: a reply. | Anaesthesia | 2020 |
| 29432858 | GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. | J Clin Epidemiol | 2019 |